Graphene-Info: the graphene experts

Graphene is the strongest, thinnest and most conductive material known to man, that can unlock countless applications in electronics, energy, composite materials, medicine, aerospace and more. Graphene-Info, established in 2009, is the world's leading graphene industry portal - offering a web publication, newsletter, market insights, market reports, and industry connections.

Researchers announce graphene plasmon breakthrough to advance photonic-electronic technology

NTT Corporation, along with The University of Tokyo and National Institute for Materials Science (NIMS), showed that graphene plasmon wave packets can be generated, manipulated and read out on-chip using terahertz electronics.  

The team managed to electrically generate and control graphene plasmon wave packets with a pulse width of 1.2 picoseconds. This result shows that the phase and amplitude of a terahertz signal can be controlled electrically by using graphene plasmons. It enables terahertz signal processing, a method different from conventional electrical circuit technology using transistors and is expected to contribute to realizing ultrahigh-speed signal processing in the future.

Read the full story Posted: Jul 25,2024

Black Swan Graphene enters strategic partnership with Broadway Colours

Black Swan Graphene has announced a commercial agreement with Broadway Colours, a UK-based manufacturer of color and additive masterbatches, plastic compounds and rotational molding powders. The Company said the partnership aims to leverage Broadway’s technical expertise, manufacturing capabilities, distribution, and market reach to fast-track the commercialization of Black Swan’s graphene products.

Broadway will use Black Swan’s graphene nanoplatelets to manufacture their Graphene Enhanced Masterbatches (GEMs) targeting a variety of sectors including consumer goods, packaging, automotive, construction, defense, marine and logistics. Its new product range will also feature a bio-based polymer GEM, which Black Swan highlighted offers an eco-friendly alternative to the existing products.  

Read the full story Posted: Jul 25,2024

Versarien raises over $700,000 to purchase of concrete and mortar testing equipment

Versarien has announced it has raised £550,000 before expenses (over USD$700,000) by way of a placing new ordinary shares.

The net proceeds will be used for the purchase of concrete and mortar testing equipment to support the ongoing CementeneTM admixture developments for BS934 accreditation, and for use in testing new mortars and products developed using the Company's 3D construction printing capability, in addition to general corporate and working capital purposes.

Read the full story Posted: Jul 25,2024

Graphene-Info launches a new version of its CVD Graphene Market Report

Today we published a new edition of our CVD Graphene Market Report, with all the latest information on this exciting material and market. The CVD graphene market is slowly emerging as applications and projects are increasing and the future looks bright for high-end graphene nanomaterials. This report adds the latest research updates, and a couple of new companies (a CVD graphene producer, and an application developer).

Graphene CVD Market Report pages layout

Reading this report, you'll learn all about:

  • How does CVD graphene differ from other graphene types
  • CVD graphene properties
  • Possible applications for CVD graphene
  • Available materials on the market

The report package also provides:

  • A list of prominent CVD graphene research activities
  • A list of all CVD graphene developers and their products
  • Datasheets and brochures from over 10 different CVD graphene makers
  • Free updates for a year

This CVD Graphene market report provides a great introduction to CVD graphene materials and applications, and covers everything you need to know about graphene produced by CVD. This is a great guide for anyone interested in applying CVD graphene in their products, or learning more about this promising new technology.

Read the full story Posted: Jul 25,2024

Abu Dhabi Department of Economic Development supports Inovartic Investment to produce graphene and graphene-enhanced products

The Abu Dhabi Department of Economic Development (ADDED) has signed a Memorandum of Understanding (MOU) with Inovartic Investment, a technology innovation company, to establish a facility in Abu Dhabi that will produce graphene and graphene-enhanced products.

The strategic collaboration marks a step towards enhancing advanced material manufacturing in the region and beyond and is aligned with Abu Dhabi’s vision to become a global hub for cutting-edge industries and technological innovation.

Read the full story Posted: Jul 24,2024

Inbrain Neuroelectronics gets ready for first-in-human testing of its graphene-based brain implant

Inbrain Neuroelectronics has designed a brain implant that can both read signals and stimulate brain impulses. Its brain-computer interface (BCI) uses graphene to create a high-resolution interface with the brain. Now, the Company has announced it is gearing up for its first-in-human testing, planed for this summer.

The technology is a type of brain-computer interface (BCI), which have been used for medical diagnostics, as communication devices for people who can’t speak, and to control external equipment, including robotic limbs. However, Inbrain intends to transform its BCI technology into a therapeutic tool for patients with neurological issues such as Parkinson’s disease. 

Read the full story Posted: Jul 24,2024

Zentek announces non-brokered private placement of units for over USD$2 million

Zentek has announced its intention to complete a non-brokered private placement of up to CAD$3 million (around USD$2,180,000). Gross proceeds of the offering will be used for working capital and general corporate purposes.

In May 2024, Zentek received a patent by the Canadian Intellectual Property Office, titled: Graphene Oxide-Cationic Silver (GO-Ag+) Nanocomposites and Their Use as a Broad-Spectrum Antimicrobial Agent. In December 2023, Zentek announced the launch of Triera Biosciences as its wholly owned subsidiary for its aptamer platform technology. Then, in May 2024, Zentek and Triera Biosciences announced achieving positive results against Avian Influenza (H5N1) using their Multivalent Aptamer Technology. 

Read the full story Posted: Jul 23,2024